首页> 美国卫生研究院文献>Frontiers in Cellular and Infection Microbiology >Development of a Multiplex PCR Assay for Detection of Shiga Toxin-Producing Escherichia coli Enterohemorrhagic E. coli and Enteropathogenic E. coli Strains
【2h】

Development of a Multiplex PCR Assay for Detection of Shiga Toxin-Producing Escherichia coli Enterohemorrhagic E. coli and Enteropathogenic E. coli Strains

机译:用于检测产志贺毒素的大肠杆菌肠出血性大肠杆菌和肠致病性大肠杆菌菌株的多重PCR检测方法的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Escherichia coli O157:H7 and other pathogenic E. coli strains are enteric pathogens associated with food safety threats and which remain a significant cause of morbidity and mortality worldwide. In the current study, we investigated whether enterohemorrhagic E. coli (EHEC), Shiga toxin-producing E. coli (STEC), and enteropathogenic E. coli (EPEC) strains can be rapidly and specifically differentiated with multiplex PCR (mPCR) utilizing selected biomarkers associated with each strain’s respective virulence genotype. Primers were designed to amplify multiple intimin (eae) and long polar fimbriae (lpfA) variants, the bundle-forming pilus gene bfpA, and the Shiga toxin-encoding genes stx1 and stx2. We demonstrated consistent amplification of genes specific to the prototype EHEC O157:H7 EDL933 (lpfA1-3, lpfA2-2, stx1, stx2, and eae-γ) and EPEC O127:H6 E2348/69 (eae-α, lpfA1-1, and bfpA) strains using the optimized mPCR protocol with purified genomic DNA (gDNA). A screen of gDNA from isolates in a diarrheagenic E. coli collection revealed that the mPCR assay was successful in predicting the correct pathotype of EPEC and EHEC clones grouped in the distinctive phylogenetic disease clusters EPEC1 and EHEC1, and was able to differentiate EHEC1 from EHEC2 clusters. The assay detection threshold was 2 × 104 CFU per PCR reaction for EHEC and EPEC. mPCR was also used to screen Argentinean clinical samples from hemolytic uremic syndrome and diarrheal patients, resulting in 91% sensitivity and 84% specificity when compared to established molecular diagnostic procedures. In conclusion, our mPCR methodology permitted differentiation of EPEC, STEC and EHEC strains from other pathogenic E. coli; therefore, the assay becomes an additional tool for rapid diagnosis of these organisms.
机译:大肠杆菌O157:H7和其他致病性大肠杆菌菌株是与食品安全威胁相关的肠道病原体,仍然是全世界发病率和死亡率的重要原因。在当前的研究中,我们调查了是否可以通过多重PCR(mPCR)快速特异性地区分肠出血性大肠杆菌(EHEC),产志贺毒素的大肠杆菌(STEC)和肠致病性大肠杆菌(EPEC)菌株。与每个菌株各自的毒力基因型相关的生物标志物。设计引物来扩增多个内膜蛋白(eae)和长极性菌毛(lpfA)变体,成束的菌毛基因bfpA以及志贺毒素编码基因stx1和stx2。我们证明了对原型EHEC O157:H7 EDL933(lpfA1-3,lpfA2-2,stx1,stx2和eae-γ)和EPEC O127:H6 E2348 / 69(eae-α, lpfA1 -1 bfpA )菌株,使用优化的mPCR方案和纯化的基因组DNA(gDNA)。腹泻型大肠杆菌中分离株的gDNA筛选。大肠菌群收集表明,mPCR分析成功地预测了在独特的系统发育疾病簇EPEC1和EHEC1中分组的EPEC和EHEC克隆的正确病理类型,并且能够区分EHEC1与EHEC2簇。对于EHEC和EPEC,每个PCR反应的测定检测阈值为2××10 4 CFU。 mPCR还用于筛选溶血性尿毒症综合征和腹泻患者的阿根廷临床样品,与确定的分子诊断程序相比,灵敏度为91%,特异性为84%。总之,我们的mPCR方法允许将EPEC,STEC和EHEC菌株与其他致病性 E进行区分。大肠杆菌;因此,该测定成为快速诊断这些生物的另一种工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号